Published in Fam Cancer on November 15, 2016
An integrated semiconductor device enabling non-optical genome sequencing. Nature (2011) 20.85
A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics (2012) 9.97
Performance comparison of benchtop high-throughput sequencing platforms. Nat Biotechnol (2012) 8.99
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell (2006) 7.33
The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet (1995) 5.83
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer (2005) 5.57
High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. Cancer Discov (2011) 5.30
Insights into DNA recombination from the structure of a RAD51-BRCA2 complex. Nature (2002) 4.22
Next-generation sequencing: from basic research to diagnostics. Clin Chem (2009) 4.18
Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes. J Mol Diagn (2013) 3.36
How many more breast cancer predisposition genes are there? Breast Cancer Res (1999) 3.10
Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med (1996) 3.04
Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res (1989) 2.54
Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet (1997) 2.53
Shining a light on dark sequencing: characterising errors in Ion Torrent PGM data. PLoS Comput Biol (2013) 2.28
Targeted, high-depth, next-generation sequencing of cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspiration tumor specimens. J Mol Diagn (2013) 2.27
Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet (2008) 1.96
Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. UKCCCR Familial Ovarian Cancer Study Group. Am J Hum Genet (1996) 1.72
Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Am J Hum Genet (1996) 1.69
Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesis. Clin Chem (1997) 1.67
Detection of low prevalence somatic mutations in solid tumors with ultra-deep targeted sequencing. Genome Biol (2011) 1.60
False positives in multiplex PCR-based next-generation sequencing have unique signatures. J Mol Diagn (2014) 1.16
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing. Oncotarget (2016) 0.90
Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population. Breast Cancer Res Treat (2010) 0.85
Heteroduplex and protein truncation analysis of the BRCA1 185delAG mutation. Hum Genet (1996) 0.83
A new mutation of BRCA2 gene in an Italian healthy woman with familial breast cancer history. Fam Cancer (2011) 0.83